Optimizing the Use of iPSC-CMs for Cardiac Regeneration in Animal Models
Heart failure (HF) is a common disease in which the heart cannot meet the metabolic demands of the body. It mostly occurs in individuals 65 years or older. Cardiac transplantation is the best option for patients with advanced HF. High numbers of patient-specific cardiac myocytes (CMs) can be generat...
Main Authors: | Alexandra Bizy, Matthew Klos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Animals |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2615/10/9/1561 |
Similar Items
-
iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development
by: Eline Simons, et al.
Published: (2023-01-01) -
Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology
by: Maria R. Pozo, et al.
Published: (2022-01-01) -
Hapln1 promotes dedifferentiation and proliferation of iPSC-derived cardiomyocytes by promoting versican-based GDF11 trapping
by: Ding-Jun Hao, et al.
Published: (2024-03-01) -
Advanced Technologies to Target Cardiac Cell Fate Plasticity for Heart Regeneration
by: Gianluca Testa, et al.
Published: (2021-09-01) -
Bioenergetic and Metabolic Impairments in Induced Pluripotent Stem Cell-Derived Cardiomyocytes Generated from Duchenne Muscular Dystrophy Patients
by: Lubna Willi, et al.
Published: (2022-08-01)